Erkan, Doruk

Publications

Sort by

Co-Author Network

selected publications

Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Autoimmunity reviews. 2022 Review GET IT
The clinical significance of low complement levels in patients with catastrophic antiphospholipid syndrome: A descriptive analysis of 73 patients from the "Catastrophic antiphospholipid syndrome registry". Lupus. 2022 Review GET IT
Mammalian Target of Rapamycin Pathway Assessment in Antiphospholipid Antibody-Positive Patients with Livedo. The Journal of rheumatology. 2022 Academic Article GET IT
Times cited: 2
Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry'). Lupus science & medicine. 2022 Academic Article GET IT
Times cited: 81
Treatment advances in antiphospholipid syndrome: 2022 update. Current opinion in pharmacology. 2022 Review GET IT
Times cited: 4
Defibrotide Inhibits Antiphospholipid Antibody-Mediated Neutrophil Extracellular Trap Formation and Venous Thrombosis. Arthritis & rheumatology (Hoboken, N.J.). 2022 Academic Article GET IT
Times cited: 10
Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository. Arthritis care & research. 2022 Academic Article GET IT
Times cited: 16
Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the "CAPS Registry". Autoimmunity reviews. 2022 Review GET IT
Times cited: 13
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION). Lupus. 2021 Academic Article GET IT
Times cited: 14
Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository. Advances in rheumatology (London, England). 2021 Academic Article GET IT
Pulmonary vasculitis in Hughes-Stovin syndrome (HSS): a reference atlas and computed tomography pulmonary angiography guide-a report by the HSS International Study Group. Clinical rheumatology. 2021 Academic Article GET IT
Times cited: 7
Expert Perspective: Management of Microvascular and Catastrophic Antiphospholipid Syndrome. Arthritis & rheumatology (Hoboken, N.J.). 2021 Academic Article GET IT
Times cited: 9
Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria. Arthritis care & research. 2021 Review GET IT
Times cited: 34
Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Autoimmunity reviews. 2021 Review GET IT
Times cited: 8
Correction to: Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update. Current rheumatology reports. 2021 Article GET IT
16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome. Lupus. 2021 Academic Article GET IT
Times cited: 5
Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update. Current rheumatology reports. 2021 Review GET IT
Times cited: 8
A critical analysis of 57 cases of Hughes-Stovin syndrome (HSS). A report by the HSS International Study Group (HSSISG). International journal of cardiology. 2021 Editorial Article GET IT
Times cited: 11
Reality Check on Antiphospholipid Antibodies in COVID-19-Associated Coagulopathy. Arthritis & rheumatology (Hoboken, N.J.). 2020 Letter GET IT
Times cited: 30
A Covid-19 Patient with Complement-Mediated Coagulopathy and Severe Thrombosis. 2020 GET IT
Times cited: 8
Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation. Journal of thrombosis and haemostasis : JTH. 2020 Academic Article GET IT
Times cited: 134
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends. Lupus. 2020 Review GET IT
Times cited: 50
Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository. The Journal of rheumatology. 2020 Academic Article GET IT
Times cited: 10
16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome. Lupus. 2020 Review GET IT
Times cited: 19
Emerging evidence of a COVID-19 thrombotic syndrome has treatment implications. Nature reviews. Rheumatology. 2020 Review GET IT
Times cited: 149
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry. Lupus. 2020 Academic Article GET IT
Times cited: 20
Recurrent thrombosis in patients with antiphospholipid antibodies and an initial venous or arterial thromboembolic event: A systematic review and meta-analysis. Journal of thrombosis and haemostasis : JTH. 2020 Review GET IT
Times cited: 11
Recurrent Complement-Mediated Thrombotic Microangiopathy in a Patient with Systemic Lupus Erythematosus: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2020 Academic Article GET IT
Times cited: 579
Corrigendum to "Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis" [AUTREV 18-11 (2019) 102395]. Autoimmunity reviews. 2020 Academic Article GET IT
Is there a role for immunosuppression in antiphospholipid syndrome?. Hematology. American Society of Hematology. Education Program. 2019 Review GET IT
Times cited: 15
Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Autoimmunity reviews. 2019 Review GET IT
Times cited: 26
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository. Journal of thrombosis and haemostasis : JTH. 2019 Academic Article GET IT
Times cited: 6
Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome. Current rheumatology reports. 2019 Review GET IT
Times cited: 12
Impact of antiphospholipid syndrome iBook on medical students' improvement of knowledge: An international randomized controlled study. European journal of rheumatology. 2019 Academic Article GET IT
Times cited: 33
Pathogenic Autoreactive T and B Cells Cross-React with Mimotopes Expressed by a Common Human Gut Commensal to Trigger Autoimmunity. Cell host & microbe. 2019 Academic Article GET IT
Times cited: 88
The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort. Seminars in arthritis and rheumatism. 2019 Academic Article GET IT
Times cited: 61
The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis. Thrombosis research. 2019 Academic Article GET IT
Times cited: 10
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository. Arthritis care & research. 2019 Academic Article GET IT
Times cited: 30
Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study. BJOG : an international journal of obstetrics and gynaecology. 2018 Academic Article GET IT
Times cited: 26
Diagnosis and Management of the Antiphospholipid Syndrome. The New England journal of medicine. 2018 Letter GET IT
Times cited: 32
Primary Thrombosis Prophylaxis in Persistently Antiphospholipid Antibody-Positive Individuals: Where Do We Stand in 2018?. Current rheumatology reports. 2018 Review GET IT
Times cited: 14
Longitudinal evaluation of diffusion tensor imaging and cognition in systemic lupus erythematosus. Lupus. 2018 Academic Article GET IT
Times cited: 25
McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome. Journal of thrombosis and haemostasis : JTH. 2018 Academic Article GET IT
Times cited: 78
The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients. Rheumatology (Oxford, England). 2018 Academic Article GET IT
Times cited: 47
Diagnosis and Management of the Antiphospholipid Syndrome. The New England journal of medicine. 2018 Review GET IT
Times cited: 392
Adult-Onset Still's Disease and Macrophage-Activating Syndrome Progressing to Lymphoma: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2018 Academic Article GET IT
Times cited: 52
Treatment of antiphospholipid syndrome beyond anticoagulation. Clinical immunology (Orlando, Fla.). 2018 Review GET IT
Times cited: 22
Infodemiology of antiphospholipid syndrome: Merging informatics and epidemiology. European journal of rheumatology. 2018 Academic Article GET IT
Times cited: 9
Variants in chondroitin sulfate metabolism genes in thrombotic storm. Thrombosis research. 2017 Academic Article GET IT
Times cited: 2
Cervical Epidural Injection in the Management of Refractory Pain and Stiffness in Spondyloarthropathy: A Case Report Series. 2017 GET IT
Times cited: 2
Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy. Blood advances. 2017 Academic Article GET IT
Times cited: 32
Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease. Lupus. 2017 Academic Article GET IT
Times cited: 43
Comment on: "The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome". Thrombosis research. 2017 Letter GET IT
Times cited: 4
Cardiovascular Disease Prevention Counseling Program for Systemic Lupus Erythematosus Patients. Arthritis care & research. 2017 Academic Article GET IT
Times cited: 6
Immunoglobulin G4-related Aortitis: A Clinical Pathology Conference Held by the Division of Rheumatology at the Hospital for Special Surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2017 Academic Article GET IT
Times cited: 486
Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension: A systematic review and meta-analysis. Autoimmunity reviews. 2017 Review GET IT
Times cited: 41
Catastrophic Antiphospholipid Syndrome: Candidate Therapies for a Potentially Lethal Disease. Annual review of medicine. 2017 Review GET IT
Times cited: 19
Belimumab in primary antiphospholipid syndrome. Lupus. 2016 Letter GET IT
Times cited: 32
Functional Magnetic Resonance Imaging of Working Memory and Executive Dysfunction in Systemic Lupus Erythematosus and Antiphospholipid Antibody-Positive Patients. Arthritis care & research. 2016 Academic Article GET IT
Times cited: 23
Miscellaneous inflammatory musculoskeletal conditions: Always a diagnostic and therapeutic challenge. Best practice & research. Clinical rheumatology. 2016 Editorial Article GET IT
AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION): 5-Year Update. Current rheumatology reports. 2016 Review GET IT
Times cited: 9
Catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis of 500 patients from the International CAPS Registry. Autoimmunity reviews. 2016 Review GET IT
Times cited: 158
Thrombotic risk assessment in antiphospholipid syndrome: the role of new antibody specificities and thrombin generation assay. Clinical and molecular allergy : CMA. 2016 Review GET IT
Times cited: 33
Mitral Valve Vegetation in Antiphospholipid Syndrome. 2016 GET IT
Times cited: 1
The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome. Turkish journal of haematology : official journal of Turkish Society of Haematology. 2016 Review GET IT
Times cited: 38
The contribution of antiphospholipid antibodies to organ damage in systemic lupus erythematosus. Lupus. 2016 Academic Article GET IT
Times cited: 30
Recognition and management of antiphospholipid syndrome. Current opinion in rheumatology. 2016 Review GET IT
Times cited: 23
The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus. European journal of rheumatology. 2015 Review GET IT
Times cited: 11
How I treat catastrophic thrombotic syndromes. Blood. 2015 Review GET IT
Times cited: 46
Rapidly Progressive Cardiac Failure Due to Giant Cell Myocarditis: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2015 Academic Article GET IT
Times cited: 21
Patients with overlap autoimmune disease differ from those with 'pure' disease. Lupus science & medicine. 2015 Academic Article GET IT
Times cited: 151
Short-term patient-centered nutrition counseling impacts weight and nutrient intake in patients with systemic lupus erythematosus. Lupus. 2015 Academic Article GET IT
Times cited: 18
The association between antiphospholipid antibodies and pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Lupus. 2015 Review GET IT
Times cited: 44
The challenge of bleeding in antiphospholipid antibody-positive patients. Current rheumatology reports. 2015 Review GET IT
Times cited: 29
Pregnancy-Related Challenges in Systemic Autoimmune Diseases. Journal of infusion nursing : the official publication of the Infusion Nurses Society. 2015 Academic Article GET IT
Times cited: 3
Social capital: a novel platform for understanding social determinants of health in systemic lupus erythematosus. Lupus. 2014 Academic Article GET IT
Times cited: 1
Lepromatous leprosy mimicking systemic lupus erythematosus: a clinical pathology conference held by the division of rheumatology at hospital for special surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2014 Academic Article GET IT
Times cited: 14
Perioperative management of antiphospholipid antibody-positive patients. Current rheumatology reports. 2014 Review GET IT
Times cited: 19
The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review. Annals of the rheumatic diseases. 2014 Review GET IT
Times cited: 93
Reply: To PMID 23861221. Arthritis care & research. 2014 Letter GET IT
Times cited: 1
Therapy: Antiphospholipid syndrome research needs more collaboration. Nature reviews. Rheumatology. 2014 Academic Article GET IT
Times cited: 2
14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends. Autoimmunity reviews. 2014 Review GET IT
Times cited: 260
Catastrophic antiphospholipid syndrome: how to diagnose a rare but highly fatal disease. Therapeutic advances in musculoskeletal disease. 2013 Review GET IT
Times cited: 45
Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis. Autoimmunity reviews. 2013 Review GET IT
Times cited: 139
Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature. Arthritis care & research. 2013 Academic Article GET IT
Times cited: 235
Top 10 clinical research developments in antiphospholipid syndrome. Current rheumatology reports. 2013 Academic Article GET IT
Times cited: 5
Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients. Clinical and experimental rheumatology. 2013 Academic Article GET IT
Times cited: 27
Comment: discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin. The Annals of pharmacotherapy. 2013 Comment GET IT
Times cited: 3
Systemic Lupus Erythematosus Associated with Rowell's Syndrome: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2013 Academic Article GET IT
Times cited: 115
A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients. Annals of the rheumatic diseases. 2013 Academic Article GET IT
Times cited: 95
Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab. Autoimmunity reviews. 2013 Academic Article GET IT
Times cited: 174
Could statins be a new therapeutic option for antiphospholipid syndrome patients?. Expert review of hematology. 2013 Editorial Article GET IT
Times cited: 6
A pilot open-label phase II trial of rituximab for non-criteria manifestations of antiphospholipid syndrome. Arthritis and rheumatism. 2013 Academic Article GET IT
Times cited: 198
Site differences in mild cognitive dysfunction (MCD) among patients with systemic lupus erythematosus (SLE). Lupus. 2013 Academic Article GET IT
Times cited: 11
The optimal tool for assessment of organ damage in antiphospholipid syndrome. The Journal of rheumatology. 2013 Letter GET IT
Times cited: 11
Clinical causes and treatment of the thrombotic storm. Expert review of hematology. 2012 Review GET IT
Times cited: 21
Cognitive or cosmetic dysfunction? 2012 GET IT
Churg-strauss syndrome with eosinophilic myocarditis: a clinical pathology conference held by the division of rheumatology at hospital for special surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2012 Academic Article GET IT
Times cited: 25
APS ACTION--AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking. Lupus. 2012 Academic Article GET IT
Times cited: 48
Belimumab in systemic lupus erythematosus: an update for clinicians. Therapeutic advances in chronic disease. 2012 Academic Article GET IT
Times cited: 15
Research studies and their implications for social work practice in a multidisciplinary center for lupus care. Social work in health care. 2012 Academic Article GET IT
Clinical assessment and management of cytopenias in lupus patients. Current rheumatology reports. 2011 Review GET IT
Times cited: 25
Thrombotic storm revisited: preliminary diagnostic criteria suggested by the thrombotic storm study group. The American journal of medicine. 2011 Review GET IT
Times cited: 33
Antiphospholipid Syndrome Clinical Research Task Force report. Lupus. 2011 Academic Article GET IT
Times cited: 29
Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies. Lupus. 2011 Academic Article GET IT
Times cited: 389
Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand?. Current rheumatology reports. 2011 Review GET IT
Times cited: 61
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus. 2011 Academic Article GET IT
Times cited: 79
Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations. Lupus. 2011 Academic Article GET IT
Times cited: 77
Cyclophosphamide responsive interstitial lung disease in "overlap syndrome": a clinical pathology conference held by the division of rheumatology at the hospital for special surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2010 Academic Article GET IT
Times cited: 952
Catastrophic antiphospholipid syndrome: updated diagnostic algorithms. Autoimmunity reviews. 2010 Review GET IT
Times cited: 120
Large-vessel granulomatous vasculitis in Crohn's disease: a clinical pathology conference held by the division of rheumatology at hospital for special surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2010 Academic Article GET IT
Times cited: 40
Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome. Pathophysiology : the official journal of the International Society for Pathophysiology. 2010 Academic Article GET IT
Times cited: 15
Antiphospholipid syndrome treatment beyond anticoagulation: are we there yet?. Lupus. 2010 Review GET IT
Times cited: 54
Non-criteria manifestations of antiphospholipid syndrome. Lupus. 2010 Academic Article GET IT
Times cited: 59
Risk quantification in antiphospholipid syndrome. Women's health (London, England). 2010 Comment GET IT
Moderate versus high-titer persistently anticardiolipin antibody positive patients: are they clinically different and does high-titer anti-beta 2-glycoprotein-I antibody positivity offer additional predictive information?. Lupus. 2009 Academic Article GET IT
Times cited: 29
Hepatitis C- and human immunodeficiency virus-induced hypersensitivity vasculitis: a clinical pathology conference held by the division of rheumatology at hospital for special surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2009 Academic Article GET IT
Times cited: 604
Overlap between systemic lupus erythematosus and Kikuchi Fujimoto disease: a clinical pathology conference held by the Department of Rheumatology at Hospital for Special Surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2009 Conference Paper GET IT
Times cited: 203
Catastrophic antiphospholipid syndrome: treatment, prognosis, and the risk of relapse. Clinical reviews in allergy & immunology. 2009 Review GET IT
Times cited: 44
New approaches for managing antiphospholipid syndrome. Nature clinical practice. Rheumatology. 2009 Review GET IT
Times cited: 55
Antiphospholipid syndrome. Progress in cardiovascular diseases. 2009 Review GET IT
Times cited: 57
Catastrophic antiphospholipid syndrome triggered by sepsis. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2008 Conference Paper GET IT
Times cited: 55
Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. Rheumatology (Oxford, England). 2008 Academic Article GET IT
Times cited: 64
Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment. Seminars in thrombosis and hemostasis. 2008 Review GET IT
Times cited: 32
Anti-neutrophil cytoplasmic antibody (c-ANCA) positive recurrent eosinophilic fasciitis responsive to cyclophosphamide: a clinical pathology conference held by the Division of Rheumatology at Hospital for Special Surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2007 Conference Paper GET IT
Times cited: 40
Subclinical carotid atherosclerosis in a patient with systemic lupus erythematosus. 2007 GET IT
Times cited: 1
Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Annals of the rheumatic diseases. 2007 Academic Article GET IT
Times cited: 40
Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals. Arthritis and rheumatism. 2007 Academic Article GET IT
Times cited: 318
Primary antiphospholipid syndrome presenting as HELLP syndrome: a clinical pathology conference held by the Division of Rheumatology at Hospital for Special Surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2007 Conference Paper GET IT
Times cited: 586
Assessment of the 2006 revised antiphospholipid syndrome classification criteria. Annals of the rheumatic diseases. 2007 Academic Article GET IT
Times cited: 77
Pulmonary nodules in an infliximab-treated rheumatoid arthritis patient: a clinical pathology conference held by the Division of Rheumatology at Hospital for Special Surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2007 Conference Paper GET IT
Times cited: 1379
The clinical spectrum of catastrophic antiphospholipid syndrome in the absence and presence of lupus. The Journal of rheumatology. 2007 Academic Article GET IT
Times cited: 94
Tumor-induced osteomalacia. 2007 GET IT
Times cited: 12
An unusual case of granulomatous lung disease. A clinical pathology conference held by the Department of Rheumatology at Hospital for Special Surgery. HSS journal : the musculoskeletal journal of Hospital for Special Surgery. 2006 Conference Paper GET IT
Times cited: 193
Lupus and thrombosis. The Journal of rheumatology. 2006 Editorial Article GET IT
Times cited: 28
Cardiac manifestations in the antiphospholipid syndrome. Rheumatic diseases clinics of North America. 2006 Review GET IT
Times cited: 40
Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients. Arthritis and rheumatism. 2006 Academic Article GET IT
Times cited: 241
Therapeutic and prognostic considerations in catastrophic antiphospholipid syndrome. Autoimmunity reviews. 2006 Review GET IT
Times cited: 55
Antiphospholipid syndrome. Current opinion in rheumatology. 2006 Review GET IT
Times cited: 35
New treatments for antiphospholipid syndrome. Rheumatic diseases clinics of North America. 2006 Review GET IT
Times cited: 39
Catastrophic antiphospholipid syndrome. Journal of intensive care medicine. 2006 Review GET IT
Times cited: 64
Real world experience with antiphospholipid antibody tests: how stable are results over time?. Annals of the rheumatic diseases. 2005 Academic Article GET IT
Times cited: 61
Warfarin in antiphospholipid syndrome--time to explore new horizons. The Journal of rheumatology. 2005 Editorial Article GET IT
Times cited: 12
Cardiac involvement in the antiphospholipid syndrome. Lupus. 2005 Review GET IT
Times cited: 87
Interferon induced digital artery vasculitis. 2005 GET IT
Times cited: 1
Methotrexate use in rheumatoid arthritis is associated with few clinically significant liver function test abnormalities. Clinical and experimental rheumatology. 2005 Academic Article GET IT
Times cited: 27
Challenges in bringing the bench to bedside in drug development for SLE. Nature reviews. Drug discovery. 2004 Review GET IT
Times cited: 40
What is antiphospholipid syndrome?. Current rheumatology reports. 2004 Review GET IT
Times cited: 35
Intravenous immunoglobulin and antiphospholipid syndrome: comment on the article by Erkan et al. Arthritis and rheumatism. 2004 Letter GET IT
Times cited: 3
Do etanercept-naive patients with rheumatoid arthritis respond better to infliximab than patients for whom etanercept has failed?. Annals of the rheumatic diseases. 2004 Letter GET IT
Times cited: 26
Behçet's disease: does lack of knowledge result in under-diagnosis?. Clinical and experimental rheumatology. 2004 Letter GET IT
Times cited: 3
How much warfarin is enough in APS related thrombosis?. Thrombosis research. 2004 Review GET IT
Times cited: 10
Is Hughes-Stovin syndrome Behçet's disease? 2004 GET IT
Times cited: 63
Catastrophic antiphospholipid syndrome: where do we stand?. Arthritis and rheumatism. 2003 Review GET IT
Times cited: 98
Eligibility of rheumatoid arthritis patients seen in clinical practice for rheumatoid arthritis clinical trials: comment on the article by Sokka and Pincus. Arthritis and rheumatism. 2003 Letter GET IT
Times cited: 5
Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies: comment on the article by Sairam et al. Clinical rheumatology. 2003 Letter GET IT
Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events. Arthritis and rheumatism. 2003 Academic Article GET IT
Times cited: 33
New insights into pregnancy-related complications in systemic lupus erythematosus. Current rheumatology reports. 2003 Review GET IT
Times cited: 14
Treatment of the antiphospholipid syndrome. The New England journal of medicine. 2003 Editorial Article GET IT
Times cited: 76
Long term outcome of catastrophic antiphospholipid syndrome survivors. Annals of the rheumatic diseases. 2003 Academic Article GET IT
Times cited: 132
Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report. Lupus. 2003 Conference Paper GET IT
Times cited: 116
Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003 Conference Paper GET IT
Times cited: 672
Pregnancy outcomes following total hip arthroplasty: a preliminary study and review of the literature. Orthopedics. 2003 Academic Article GET IT
Times cited: 12
The role of cardiac magnetic resonance imaging in antiphospholipid syndrome. 2002 GET IT
Times cited: 11
The relation between antiphospholipid syndrome-related pregnancy morbidity and non-gravid vascular thrombosis: a review of the literature and management strategies. Current rheumatology reports. 2002 Review GET IT
Times cited: 19
Treatment of catastrophic antiphospholipid syndrome with defibrotide, a proposed vascular endothelial cell modulator. 2002 GET IT
Times cited: 74
A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford, England). 2002 Academic Article GET IT
Times cited: 270
Monitoring methotrexate hepatic toxicity in rheumatoid arthritis: is it time to update the guidelines?. The Journal of rheumatology. 2002 Editorial Article GET IT
Times cited: 25
Decreased flares of rheumatoid arthritis during the first year of etanercept treatment: further evidence of clinical effectiveness in the "real world". Annals of the rheumatic diseases. 2002 Academic Article GET IT
Times cited: 14
Physician treatment preferences in rheumatoid arthritis of differing disease severity and activity: the impact of cost on first-line therapy. Arthritis and rheumatism. 2002 Academic Article GET IT
Times cited: 30
Diagnostic usefulness of 3 dimensional gadolinium enhanced magnetic resonance venography in antiphospholipid syndrome. 2002 GET IT
Times cited: 1
Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations. 2002 GET IT
Times cited: 92
Dual antibody reactivity to beta2-glycoprotein I and protein S: increased association with thrombotic events in the antiphospholipid syndrome. Lupus. 2002 Academic Article GET IT
Times cited: 43
Etanercept in the treatment of severe, resistant psoriatic arthritis: continued efficacy and changing patterns of use after two years. Clinical and experimental rheumatology. 2002 Letter GET IT
Times cited: 16
Protein-losing enteropathy in systemic lupus erythematosus: report of a severe, persistent case and review of pathophysiology. Lupus. 2002 Review GET IT
Times cited: 53
Reporting consistency in systemic lupus erythematosus patients: how reliable are patient histories?. Lupus. 2002 Academic Article GET IT
Times cited: 2
High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin. Arthritis and rheumatism. 2001 Academic Article GET IT
Times cited: 173
Morning stiffness: how common is it and does it correlate with physician and patient global assessment of disease activity?. The Journal of rheumatology. 2001 Letter GET IT
Times cited: 19
Lupus anticoagulant--hypoprothrombinemia syndrome and pregnancy. Lupus. 2001 Letter GET IT
Times cited: 5
VATER association: is it recognised by rheumatologists? 2001 GET IT
Primary antiphospholipid syndrome: functional outcome after 10 years. The Journal of rheumatology. 2000 Academic Article GET IT
Times cited: 75
Severe guillain-barre-like peripheral neuropathy in a patient with systemic lupus erythematosus: recovery after two separate accidental burn injuries. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 2000 Academic Article GET IT
Clinical Images: Ehlers-Danlos syndrome presenting as olecranon bursitis. 2000 GET IT
A case of VATER association mimicking spondylarthropathy. Clinical and experimental rheumatology. 2000 Letter GET IT
Times cited: 1
A preliminary study of etanercept in the treatment of severe, resistant psoriatic arthritis. Clinical and experimental rheumatology. 2000 Academic Article GET IT
Times cited: 48
Lupus anticoagulant-hypoprothrombinemia syndrome associated with systemic lupus erythematosus: report of 2 cases and review of literature. Lupus. 1999 Review GET IT
Times cited: 58
Current management of mitral valve incompetence associated with coronary artery disease. Journal of cardiac surgery. 1989 Review GET IT
Times cited: 21

more ...

less ...

Background

education and training

M.P.H., The Johns Hopkins University Bloomberg School of Public Health 2007
M.D., Hacettepe University Faculty of Medicine (Turkey) 1995

Contact

full name

Doruk Erkan

primary email

doe2001@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Doruk Erkan Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage